Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvo save search
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
Published: 2023-11-28 (Crawled : 12:30) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: -2.88%
H: 0.37%
C: -0.43%
PDSB | $5.25 -0.19% 0.0% 550K
|
Health Technology
|
| O: -6.86%
H: 0.7%
C: -6.49%
PODD | $192.19 1.64% -3.32% 930K
|
Health Technology
|
| O: -0.18%
H: 1.19%
C: -0.21%
biotech financial
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-27 (Crawled : 14:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
repurchase
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
Published: 2023-11-23 (Crawled : 16:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
| Email alert
Add to watchlist
expansion
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-20 (Crawled : 15:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
| Email alert
Add to watchlist
repurchase
Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published: 2023-11-15 (Crawled : 22:00) - prnewswire.com
LLY 2 d | $584.04 -1.18% 0.34% 3.6M
|
Health Technology
|
| O: -3.12%
H: 0.61%
C: -0.46%
VRTX | $351.16 -1.03% 0.7% 1.1M
|
Health Technology
|
| O: -5.15%
H: 0.38%
C: -2.2%
SNY | $46.72 -0.06% -0.06% 1.1M
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: 0.0%
companies diabetes study market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-14 (Crawled : 11:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-13 (Crawled : 20:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
repurchase
Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-13 (Crawled : 12:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
Novo Nordisk A/S: Semaglutide 2.4 mg (Wegovy®) cardiovascular outcomes data presented at American Heart Association Scientific Sessions and simultaneously published in New England Journal of Medicine
Published: 2023-11-11 (Crawled : 16:20) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
| Email alert
Add to watchlist
wegovy association sessions heart cardiovascular
Global Glucagon-like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc., AstraZeneca PLC, Sanofi, Novo Nordisk Among Others
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
SNY | $46.72 -0.06% -0.06% 1.1M
|
Health Technology
| Email alert
Add to watchlist
LLY 2 d | $584.04 -1.18% 0.34% 3.6M
|
Health Technology
| Email alert
Add to watchlist
AZN | $64.79 0.31% 0.03% 3.6M
|
Health Technology
| Email alert
Add to watchlist
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $125.0 -2.72% 8.8% 3.4K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $94.0 1.34% 1.34% 860
|
Health Technology
| Email alert
Add to watchlist
report astrazeneca global market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-10 (Crawled : 12:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
Novo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark
Published: 2023-11-10 (Crawled : 07:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
expansion
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-07 (Crawled : 15:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: -0.32%
H: 1.23%
C: 0.92%
Novo Nordisk A/S purchases B shares worth DKK 4,886 million from Novo Holdings A/S under the 2023 share repurchase programme
Published: 2023-11-06 (Crawled : 21:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: -0.32%
H: 1.23%
C: 0.92%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-06 (Crawled : 21:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: -0.32%
H: 1.23%
C: 0.92%
repurchase
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-06 (Crawled : 13:30) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: 1.44%
H: 1.67%
C: 1.25%
Addressing the Global HIV Challenge: Market for Diagnostics and Therapeutics Plays a Crucial Role in Combating HIV/AIDS
Published: 2023-11-03 (Crawled : 17:00) - prnewswire.com
TMO | $496.13 0.08% 0.0% 1.2M
|
Health Technology
|
| O: 2.32%
H: 0.0%
C: 0.0%
QGEN | $41.45 0.71% 0.92% 880K
|
Health Technology
|
| O: 2.29%
H: 0.0%
C: 0.0%
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: -2.5%
H: 0.0%
C: 0.0%
NVS | $98.13 0.24% -0.16% 1.2M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
JNJ | $158.38 2.41% 0.0% 10M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
BDX S | $238.25 0.88% 0.37% 1.5M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
SNY | $46.72 -0.06% -0.06% 1.1M
|
Health Technology
|
| O: -3.04%
H: 0.0%
C: 0.0%
QGEN | $41.45 0.71% 0.92% 880K
|
Health Technology
|
| O: 2.29%
H: 0.0%
C: 0.0%
global hiv diagnostics therapeutics market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-03 (Crawled : 14:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: -2.5%
H: 0.0%
C: 0.0%
Novo Nordisk's sales increased by 29% in Danish kroner and by 33% at constant exchange rates to DKK 166.4 billion in the first nine months of 2023
Published: 2023-11-02 (Crawled : 07:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: 4.05%
H: 0.96%
C: -0.35%
sales
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-01 (Crawled : 17:00) - globenewswire.com
NVO | $100.4 -1.41% 0.3% 4.6M
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
repurchase
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
ID 4 | $0.077 -9.41% 25.97% 420K
|
Finance
BKKT 4 | $1.88 25.33% 14.89% 4.8M
|
MGLD | $1.03 7.77% 14K
|
Manufacturing
CZOO | $0.4316 -6.52% 6.7% 65K
|
SATX | $0.4226 -1.72% 6.48% 29K
|
n/a
CCJ | $45.4 -1.13% 4.6% 3.9M
|
Non-Energy Minerals
AUMN | $0.562 0.34% 4.5% 360K
|
Non-Energy Minerals
JBL | $116.91 1.38% 4.3% 2M
|
Electronic Technology
SAIC 4 | $119.92 2.14% 4.24% 460K
|
Technology Services
CULP 4 | $5.06 -0.59% 3.95% 29K
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.